Clinical Trial Update: Safety and Efficacy of Aliskiren + Hydrochlorothiazide (± Amlodipine 5 mg) in Patients With Moderate Hypertension [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the safety and efficacy of aliskiren with hydrochlorothiazide (± amlodipine 5 mg) in patients with moderate hypertension has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Amlodipine (amlodipine)
• HYDROCHLOROTHIAZIDE (hydrochlorothiazide)
• Tekturna (aliskiren)

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2011-02-01